Catriona Yale insider trades
Open-market stock purchases and sales by Catriona Yale, Chief Development Officer at Akero Therapeutics, Inc, from SEC Form 4 filings since Dec 13, 2019.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $100K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $100K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $2.6M |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | — |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | — |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $100K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $2.1M |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $3.6M |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $705K |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $2.1M |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc | Sold (not open market) | $1.1M |
| Nov 4, 2025 | AKRO Akero Therapeutics, Inc | Bought (not open market) | — |
| Nov 4, 2025 | AKRO Akero Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- AKRO Akero Therapeutics, Inc: 73 sales, last Dec 9, 2025